Skip to main content
SpringerLink
Log in

The role of positron emission tomography in breast cancer: a short review

  • short review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Abstract

Positron emission tomography (PET) provides information about abnormal metabolic features associated with cancer, and its role in breast cancer has been widely investigated. In the past several years, combined imaging systems, such as PET/CT and PET/MRI, and dedicated breast PET devices, such as PEM and MAMMI-PET, have been developed and implemented. These new techniques have become an effective oncologic tool for staging, re-staging, monitoring response to treatment, and estimation of the long-term prognosis. The aim of this review is to summarize the established and emerging PET imaging techniques and to discuss their value in the management of breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Malvezzi M, Bertuccio P, Rosso T, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. 2015;26:779–86. doi:10.1093/annonc/mdv001.

  2. Bosetti C, Bertuccio P, Levi F, et al. The decline in breast cancer mortality in Europe: an update (to 2009). Breast. 2012;21:77–82.

    Article  PubMed  Google Scholar 

  3. Carlson RW, Allred DC, Anderson BO, et al. Invasive breast cancer. J Natl Compr Canc Netw. 2011;9:136–222.

    CAS  PubMed  Google Scholar 

  4. Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010;46(8):1296–316.

    Article  PubMed  Google Scholar 

  5. Pinker K, Bogner W, Baltzer P, Gruber S, Bickel H, Brueck B, et al. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging. Invest Radiol. 2014;49(6):421–30.

    Article  CAS  PubMed  Google Scholar 

  6. Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, et al. Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study. Clin Cancer Res. 2014;20(13):3540–9. doi:10.1158/1078-0432.CCR-13-2810.

  7. Baltzer PA, Dietzel M. Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T—systematic review and meta-analysis. Radiology. 2013;267(3):735–46.

  8. Kong EJ, Chun KA, Bom HS, Lee J, Lee SJ, Cho IH. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma. Hell J Nucl Med. 2014;17(3):171–6.

    PubMed  Google Scholar 

  9. Warburg O. Metabolism of tumors. London:constable and Company; 1930.

    Google Scholar 

  10. Groheux D, Espié M, Giacchetti S, Hindié E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 2013;266(2):388–405. doi:10.1148/radiol.12110853.

  11. Avril N, Rosé CA, Schelling M, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol. 2000;18(20):3495–502.

    CAS  PubMed  Google Scholar 

  12. Kalles V, Zografos GC, Provatopoulou X, et al. The current status of positron emission mammography in breast cancer. Breast Cancer. 2013;20(2):123–30.

    Article  PubMed  Google Scholar 

  13. Yoon H, Kang KW, Chun IK, Cho N, et al. Correlation of breast cancer subtypes, based on estrogen receptor, progesteron receptor, and HER2 with functional imaging parameters from 68GA-RDG PET/CT and 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2014;41:1534–43.

    Article  CAS  PubMed  Google Scholar 

  14. Mavi A, Urhan M, Yu JQ, et al. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med. 2006;47(9):1440–6.

    PubMed  Google Scholar 

  15. Blodgett TM, Meltzer CC, Townsend DW. PET/CT: form and function. Radiology. 2007;242:360–85.

    Article  PubMed  Google Scholar 

  16. Berg WA, Madsen KS, Schilling K, et al. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer. AJR Am J Roentgenol. 2012;198:219–32.

    Article  PubMed  Google Scholar 

  17. Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, et al. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. Int J Radiat Oncol Biol Phys. 2012;83:1381–6.

    Article  PubMed  Google Scholar 

  18. Park JS, Moon WK, Lyou CY, Cho N, Kang KW, Chung JK. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emmision tomography. Acta Radiol. 2011;52(1):21–8.

  19. Tatsumi M, Cohade C, Mourtzikos KA, et al. Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging. 2006;33(3):254–62.

    Article  PubMed  Google Scholar 

  20. Rosen EL, Eubank W, Mankoff DA. FDG PET, PET/CT, and breast cancer imaging. Radiographics. 2007;27:S215–29.

  21. Magometschnigg HF, Helbich TH, Brader P, et al. Molecular imaging for the characterization of breast tumours. Expert Rev Anticancer Ther. 2014;14(6):711–22.

    Article  CAS  PubMed  Google Scholar 

  22. Choi YJ, Shin YD, Kang YH, et al. The effects of preoperative (18)F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study. J Breast Cancer. 2012;15(4):441–8.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Taneja S, Jena A, Goel R, Sarin R, et al. Simultaneous whole-body 18F-FDG PET/MRI in primary staging of breast cancer: a pilot study. Eur J Radiol. 2014;83:2231–9.

    Article  PubMed  Google Scholar 

  24. Pinker K, Bickel H, Magometschnigg H, et al. Molecular imaging of breast tumours with PET/MRI—proof of concept. 6th EMIM. 2011;8:92.

  25. Eo JS, Chun IK, Paeng JC, et al. Imaging sensitivity of dedicated positron emission mammography in relation to tumour size. Breast. 2012;21(1):66–71. doi:10.1016/j.breast.2011.08.002. Epub 2011 Aug 25.

    Article  PubMed  Google Scholar 

  26. Mankoff DA, Sprecht JM. [18F]Fluorodeoxyglucose positron emission tomography—computed tomography in breast cancer: when… and when not? J Clin Oncol. 2012;30(12):1252–4.

    Article  CAS  PubMed  Google Scholar 

  27. Koolen BB, Vogel WV, Vrancken Peeters MJTFD, et al. Molecular imaging in breast cancer: from whole-body PET/CT to dedicated breast PET. J Oncol. 2012. doi:10.1155/2012/438647.

  28. Riedl CC, Slobod E, Jochelson M, et al. Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years. J Nucl Med. 2014;55(10):1578–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18–20, 1090, Vienna, Austria

    Maria Adele Marino MD,  Thomas H. Helbich MD, MSc, MBA &  Katja Pinker MD, EBBI

  2. Department of Biomedical Sciences and Morphologic and Functional Imaging, Policlinico G.Martino, University of Messina, Messina, Italy

    Maria Adele Marino MD &  Alfredo Blandino MD

Authors
  1. Maria Adele Marino MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas H. Helbich MD, MSc, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alfredo Blandino MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katja Pinker MD, EBBI
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katja Pinker MD, EBBI.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marino, M., Helbich, T., Blandino, A. et al. The role of positron emission tomography in breast cancer: a short review. memo 8, 130–135 (2015). https://doi.org/10.1007/s12254-015-0210-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-015-0210-z

Keywords

Search

Navigation